explore -WSS

explore

author：leisure time 2025-10-01 04:45:09 - browse：9684

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Women's World Cup brings attention to abuse in soccer

WSS

The simple reason for the increase in autism diagnosis

Medical experts exlpore how to eliminate bias in clinical algorithms

Illumina to lay off 10% of research and development team

Supreme Court strikes down Biden student loan forgiveness program

Thousands protest in Iraq for a second day over burning of Quran in Sweden

GOP inquiry over gain

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Medical leaders decry Supreme Court decision on affirmative action

ADA: All diabetes patients should be screened for liver condition

Hollywood unions extend contract negotiations for actors

Women's World Cup brings attention to abuse in soccer

Medical records are filled with copy

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Anesthesiologist group: stop taking Ozempic before surgery

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

The cancer drug shortage isn’t new — and neither are the solutions

Supreme Court strikes down Biden student loan forgiveness program

focus

EU fines Illumina $475 million over Grail acquisition

Illumina to lay off 10% of research and development team

Eating disorder hotline's move to chatbot carried cost for volunteers

The simple reason for the increase in autism diagnosis

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

focus

entertainment

hotspot

hotspot